Order Article Reprints

Niba ETE, Nishio H, Wijaya YOS, Ar Rochmah M, Takarada T, Takeuchi A, Kimizu T, Okamoto K, Saito T, Awano H, et al. Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy. Genes. 2022; 13(2):205. https://doi.org/10.3390/genes13020205

Niba, Emma Tabe Eko, Hisahide Nishio, Yogik Onky Silvana Wijaya, Mawaddah Ar Rochmah, Toru Takarada, Atsuko Takeuchi, Tomokazu Kimizu, Kentaro Okamoto, Toshio Saito, Hiroyuki Awano, and et al. 2022. "Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy" Genes 13, no. 2: 205. https://doi.org/10.3390/genes13020205

Niba, E. T. E., Nishio, H., Wijaya, Y. O. S., Ar Rochmah, M., Takarada, T., Takeuchi, A., Kimizu, T., Okamoto, K., Saito, T., Awano, H., Takeshima, Y., & Shinohara, M. (2022). Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy. Genes, 13(2), 205. https://doi.org/10.3390/genes13020205